Oct 8, 2020 - Politics & Policy

DNC War Room launches "Had Enough?" ad taking on Trump's pandemic response

Mike Allen, author of AM

Via DNC War Room

The DNC War Room on Thursday will begin airing a new TV ad, "Had Enough?," that takes on President Trump's claim that his administration has done a "great job" on the pandemic.

The state of play: This is a six-figure buy in swing states and D.C. on both broadcast and cable.

  • This is the 13th ad the DNC War Room has released since June.

What they're saying: "Across the country, workers are facing layoffs, millions of families are struggling to make ends meet," said DNC War Room senior spokesperson and advisor Lily Adams.

  • "[T]o this day, many family members still can’t say goodbye to their loved ones in person — that’s not what a 'great' job looks like, that’s a catastrophe."

Go deeper: Watch the ad

Subscribe to Axios AM/PM for a daily rundown of what's new and why it matters, directly from Mike Allen.
Please enter a valid email.
Please enter a valid email.
Server error. Please try a different email.
Subscribed! Look for Axios AM and PM in your inbox tomorrow or read the latest Axios AM now.

Go deeper

Axios
Updated 16 hours ago - World

France becomes 2nd Western European country to top 1M coronavirus cases

French President Emmanuel Macron at the Seine Saint Denis prefecture headquarters in Paris, on Tuesday. Photo: Ludovic Marin/POOL/AFP via Getty Images

France has become the second country in Western Europe to surpass 1 million COVID-19 cases, Johns Hopkins University data shows

The big picture: France had reported 1,000,369 cases and 34,075 deaths from the coronavirus by Thursday morning, per JHU. French President Emmanuel Macron declared a state of health emergency and imposed a curfew on virus hot spots earlier this month. Spain on Wednesday became the first Western European nation to top 1 million cases.

Go deeper (<1 min. read)Arrow
Marisa Fernandez
12 hours ago - Health

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.

Go deeper (1 min. read)Arrow
Alison Snyder, Eileen Drage O'Reilly
12 hours ago - Science

How the coronavirus pandemic could end

Illustration: Sarah Grillo/Axios

It's still the early days of the coronavirus pandemic, but history, biology and the knowledge gained from our first nine months with COVID-19 point to how the pandemic might end.

The big picture: Pandemics don't last forever. But when they end, it usually isn't because a virus disappears or is eliminated. Instead, they can settle into a population, becoming a constant background presence that occasionally flares up in local outbreaks.

Go deeper (3 min. read)Arrow